Investigation of interavenous Ketamine anti depressant effects on major depressive disorder patients
Phase 4
- Conditions
- Major depressive disorder.Severe depressive episode without psychotic symptoms
- Registration Number
- IRCT2015030921072N2
- Lead Sponsor
- Babol University of Medical Sciences, Research Deputy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with major depressive disorder according to DSM-V criteria with different severity and with out psychotic feature were selected.this patient also lacks a somatoform disorder and personality disorder co-morbidity, hypertension and heart disease and over the last month are not under medical treatment.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression. Timepoint: Pre intervension, 2, 7, 30, 60 dayes post intervension. Method of measurement: Hamilton and Beck test.
- Secondary Outcome Measures
Name Time Method Drug dose. Timepoint: Pre intervension, 2, 7, 30, 60 dayes post intervension. Method of measurement: Hamilton and Beck test.;Method Of Injection. Timepoint: Pre intervension, 2, 7, 30, 60 dayes post intervension. Method of measurement: Hamilton and Beck test.